CUSIP NO. 05105P107 | 13D | Page 2 of 26 Pages |
1 |
NAME
OF REPORTING
SS OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
DCM VI, L.P. (“DCM VI”) |
2 |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
(a) ¨ (b) x |
3 |
SEC
USE ONLY |
4 |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Cayman Islands |
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON
WITH |
5 |
SOLE
VOTING POWER
4,438,408 common shares (which includes 269,490 shares underlying warrants to purchase common stock held by DCM VI), except that
DCM Investment Management VI, L.P. (“DGP VI”), the general partner of DCM VI, and DCM International VI, Ltd. (“UGP
VI”), the general partner of DGP VI, may be deemed to have sole power to vote these shares, and F. Hurst Lin (“Lin”)
and Matthew C. Bonner (“Bonner”), the directors of UGP VI, may be deemed to have shared power to vote these shares. |
|
6 |
SHARED
VOTING POWER
See response to row 5. |
|
7 |
SOLE
DISPOSITIVE POWER
4,438,408 common shares (which includes 269,490 shares underlying warrants to purchase common stock held by DCM VI), except that
DGP VI, the general partner of DCM VI, and UGP VI, the general partner of DGP VI, may be deemed to have sole power to dispose of
these shares, and Lin and Bonner, the directors of UGP VI, may be deemed to have shared power to dispose of these shares. |
|
8 |
SHARED
DISPOSITIVE POWER
See response to row 7. |
9 |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON |
4,438,408 |
10 |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES* |
¨ |
11 |
PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW 9 |
11.9% |
12 |
TYPE
OF REPORTING PERSON* |
PN |
CUSIP NO. 05105P107 | 13D | Page 3 of 26 Pages |
1 |
NAME
OF REPORTING
SS OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
DCM Investment Management VI, L.P. (“DGP VI”) |
2 |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
(a) ¨ (b) x |
3 |
SEC
USE ONLY |
4 |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Cayman Islands |
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON
WITH |
5 |
SOLE
VOTING POWER
4,438,408 common shares (which includes 269,490 shares underlying warrants to purchase common stock held by DCM VI) all
of which are directly owned by DCM VI. DGP VI, the general partner of DCM VI, may be deemed to have sole power to vote these
shares, except that UGP VI, the general partner of DGP VI, may be deemed to have sole power to vote these shares, and Lin and Bonner,
the directors of UGP VI, may be deemed to have shared power to vote these shares. |
|
6 |
SHARED
VOTING POWER
See response to row 5. |
|
7 |
SOLE
DISPOSITIVE POWER
4,438,408 common shares (which includes 269,490 shares underlying warrants to purchase common stock held by DCM VI) all
of which are directly owned by DCM VI. DGP VI, the general partner of DCM VI, may be deemed to have sole power to dispose
of these shares, except that UGP VI, the general partner of DGP VI, may be deemed to have sole power to dispose of these shares,
and Lin and Bonner, the directors of UGP VI, may be deemed to have shared power to dispose of these shares. |
|
8 |
SHARED
DISPOSITIVE POWER
See response to row 7. |
9 |
AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH
REPORTING PERSON |
4,438,408 |
10 |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES* |
¨ |
11 |
PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW 9 |
11.9% |
12 |
TYPE
OF REPORTING PERSON* |
PN |
CUSIP NO. 05105P107 | 13D | Page 4 of 26 Pages |
1 |
NAME
OF REPORTING
SS OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
DCM International VI, Ltd. (“UGP VI”) |
2 |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
(a) ¨ (b) x |
3 |
SEC
USE ONLY |
4 |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Cayman Islands |
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON
WITH |
5 |
SOLE
VOTING POWER
4,438,408 common shares (which includes 269,490 shares underlying warrants to purchase common stock held by DCM VI) all
of which are directly owned by DCM VI. UGP VI is the general partner of DGP VI, the general partner of DCM VI, and may be
deemed to have sole power to vote these shares, except DGP VI, the general partner of DCM VI, may be deemed to have sole power to
vote these shares, and Lin and Bonner, the directors of UGP VI, may be deemed to have shared power to vote these shares. |
|
6 |
SHARED
VOTING POWER
See response to row 5. |
|
7 |
SOLE
DISPOSITIVE POWER
4,438,408 common shares (which includes 269,490 shares underlying warrants to purchase common stock held by DCM VI) all
of which are directly owned by DCM VI. UGP VI is the general partner of DGP VI, the general partner of DCM VI, and may be
deemed to have sole power to dispose of these shares, except DGP VI, the general partner of DCM VI, may be deemed to have sole power
to dispose of these shares, and Lin and Bonner, the directors of UGP VI, may be deemed to have shared power to dispose of these shares. |
|
8 |
SHARED
DISPOSITIVE POWER
See response to row 7. |
9 |
AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH
REPORTING PERSON |
4,438,408 |
10 |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES* |
¨ |
11 |
PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW 9 |
11.9% |
12 |
TYPE
OF REPORTING PERSON* |
OO |
CUSIP NO. 05105P107 | 13D | Page 5 of 26 Pages |
1 |
NAME
OF REPORTING
SS OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
A-Fund, L.P. (“A-Fund”) |
2 |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
(a) ¨ (b) x |
3 |
SEC
USE ONLY |
4 |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Cayman Islands |
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON
WITH |
5 |
SOLE
VOTING POWER
20,007 common shares, except that A-Fund Investment Management, L.P. (“A-Fund DGP”), the general partner of A-Fund, and
A-Fund International, Ltd. (“A-Fund UGP”), the general partner of A-Fund DGP, may be deemed to have sole power to vote
these shares, and Lin and Bonner, the directors of A-Fund UGP, may be deemed to have shared power to vote these shares. |
|
6 |
SHARED
VOTING POWER
See response to row 5. |
|
7 |
SOLE
DISPOSITIVE POWER
20,007 common shares, except that A-Fund DGP, the general partner of A-Fund, and A-Fund UGP, the general partner of A-Fund DGP, may
be deemed to have sole power to dispose of these shares, and Lin and Bonner, the directors of A-Fund UGP, may be deemed to have shared
power to dispose of these shares. |
|
8 |
SHARED
DISPOSITIVE POWER
See response to row 7. |
9 |
AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH
REPORTING PERSON |
20,007 |
10 |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES* |
¨ |
11 |
PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW 9 |
0.1% |
12 |
TYPE
OF REPORTING PERSON* |
PN |
CUSIP NO. 05105P107 | 13D | Page 6 of 26 Pages |
1 |
NAME
OF REPORTING
SS OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
A-Fund Investment Management, L.P. (“A-Fund DGP”) |
2 |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
(a) ¨ (b) x |
3 |
SEC
USE ONLY |
4 |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Cayman Islands |
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON
WITH |
5 |
SOLE
VOTING POWER
20,007 common shares all of which are directly owned by A-Fund. A-Fund DGP, the general
partner of A-Fund, may be deemed to have sole power to vote these shares, except that A-Fund UGP, the general partner of A-Fund DGP,
may be deemed to have sole power to vote these shares, and Lin and Bonner, the directors of A-Fund UGP, may be deemed to have shared
power to vote these shares. |
|
6 |
SHARED
VOTING POWER
See response to row 5. |
|
7 |
SOLE
DISPOSITIVE POWER
20,007 common shares all of which are directly owned by A-Fund. A-Fund DGP, the general
partner of A-Fund, may be deemed to have sole power to dispose of these shares, except that A-Fund UGP, the general partner of A-Fund
DGP, may be deemed to have sole power to dispose of these shares, and Lin and Bonner, the directors of A-Fund UGP, may be deemed
to have shared power to dispose of these shares. |
|
8 |
SHARED
DISPOSITIVE POWER
See response to row 7. |
9 |
AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH
REPORTING PERSON |
20,007 |
10 |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES* |
¨ |
11 |
PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW 9 |
0.1% |
12 |
TYPE
OF REPORTING PERSON* |
PN |
CUSIP NO. 05105P107 | 13D | Page 7 of 26 Pages |
1 |
NAME
OF REPORTING
SS OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
A-Fund International, Ltd. (“A-Fund UGP”) |
2 |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
(a) ¨ (b) x |
3 |
SEC
USE ONLY |
4 |
CITIZENSHIP
OR PLACE OF ORGANIZATION
Cayman Islands |
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON
WITH |
5 |
SOLE
VOTING POWER
20,007
common shares all of which are directly owned by A-Fund. A-Fund UGP is the general partner
of A-Fund DGP, the general partner of A-Fund, and may be deemed to have sole power to vote these shares, except A-Fund DGP, the general
partner of A-Fund, may be deemed to have sole power to vote these shares, and Lin and Bonner, the directors of A-Fund UGP, may be
deemed to have shared power to vote these shares. |
|
6 |
SHARED
VOTING POWER
See response to row 5. |
|
7 |
SOLE
DISPOSITIVE POWER
20,007
common shares all of which are directly owned by A-Fund. A-Fund UGP is the general partner
of A-Fund DGP, the general partner of A-Fund, and may be deemed to have sole power to dispose of these shares, except A-Fund DGP,
the general partner of A-Fund, may be deemed to have sole power to dispose of these shares, and Lin and Bonner, the directors of
A-Fund UGP, may be deemed to have shared power to dispose of these shares. |
|
8 |
SHARED
DISPOSITIVE POWER
See response to row 7. |
9 |
AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH
REPORTING PERSON |
20,007 |
10 |
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES* |
¨ |
11 |
PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW 9 |
0.1% |
12 |
TYPE
OF REPORTING PERSON* |
OO |
CUSIP NO. 05105P107 | 13D | Page 8 of 26 Pages |
1 |
NAME
OF REPORTING PERSON F. Hurst Lin (“Lin”) |
2 |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
(a) ¨ (b) x |
3 |
SEC
USE ONLY |
4 |
CITIZENSHIP
OR PLACE OF ORGANIZATION U.S.
Citizen |
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY EACH
REPORTING
PERSON
WITH |
5 |
SOLE
VOTING POWER
0 shares. |
6 |
SHARED
VOTING POWER
4,458,415 common shares of which 4,438,408 (which includes 269,490 shares underlying warrants to purchase common stock held by DCM
VI) are directly owned by DCM VI and 20,007 are
owned directly by A-Fund. Lin is a director of each of UGP VI, the general partner of DGP VI, which is the general partner
of DCM VI, and A-Fund UGP, the general partner of A-Fund DGP, which is the general partner
of A-Fund, and may be deemed to have shared power to vote these shares. |
7 |
SOLE
DISPOSITIVE POWER
0 shares. |
8 |
SHARED
DISPOSITIVE POWER
4,458,415
common shares of which 4,438,408 (which includes 269,490 shares underlying warrants to purchase common stock held by DCM VI) are
directly owned by DCM VI and 20,007 are owned directly by A-Fund. Lin is a director
of each of UGP VI, the general partner of DGP VI, which is the general partner of DCM VI,
and A-Fund UGP, the general partner of A-Fund DGP, which is the general partner of A-Fund, and may be deemed to have shared power
to dispose of these shares. |
9 |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON |
4,458,415 |
10 |
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES* |
¨ |
11 |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9 |
11.9% |
12 |
TYPE
OF REPORTING PERSON* |
IN |
CUSIP NO. 05105P107 | 13D | Page 9 of 26 Pages |
1 |
NAME
OF REPORTING PERSON Matthew C. Bonner (“Bonner”) |
2 |
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP* |
(a) ¨ (b) x |
3 |
SEC
USE ONLY |
4 |
CITIZENSHIP
OR PLACE OF ORGANIZATION U.S.
Citizen |
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY EACH
REPORTING
PERSON
WITH |
5 |
SOLE
VOTING POWER
0 shares. |
6 |
SHARED
VOTING POWER
4,458,415
common shares of which 4,438,408 (which includes 269,490 shares underlying warrants to purchase common stock held by DCM VI) are
directly owned by DCM VI and 20,007 are owned directly by A-Fund. Bonner is a
director of each of UGP VI, the general partner of DGP VI, which is the general partner of DCM
VI, and A-Fund UGP, the general partner of A-Fund DGP, which is the general partner of A-Fund, and may be deemed to have shared
power to vote these shares. |
7 |
SOLE
DISPOSITIVE POWER
0 shares. |
8 |
SHARED
DISPOSITIVE POWER
4,458,415
common shares of which 4,438,408 (which includes 269,490 shares underlying warrants to purchase common stock held by DCM VI) are
directly owned by DCM VI and 20,007 are owned directly by A-Fund. Bonner is a
director of each of UGP VI, the general partner of DGP VI, which is the general partner of DCM
VI, and A-Fund UGP, the general partner of A-Fund DGP, which is the general partner of A-Fund, and may be deemed to have shared
power to dispose of these shares. |
9 |
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON |
4,458,415 |
10 |
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES* |
¨ |
11 |
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9 |
11.9% |
12 |
TYPE
OF REPORTING PERSON* |
IN |
CUSIP NO. 05105P107 | 13D | Page 10 of 26 Pages |
| ITEM 1. | SECURITY
AND ISSUER. |
This
Amendment No. 2 supplements and amends the Schedule 13D that was originally filed on October 5, 2020 as amended by Amendment No. 1 filed
on October 28, 2021 (the “Original Schedule 13D”). This Amendment No. 2 relates to the common stock, par value $0.0001 per
share (the “Common Stock”), of Augmedix, Inc., a Delaware corporation (the “Company”). Information given in response
to each item shall be deemed incorporated by reference in all other items, as applicable. Capitalized terms not defined in this Amendment
No. 2 have the meanings ascribed to them in the Original Schedule 13D. The Company’s principal executive offices are located at
1161 Mission Street, Suite LL, San Francisco, California, 94103.
| ITEM 2. | IDENTITY
AND BACKGROUND. |
(a-c,
f) This Schedule 13D is being filed on behalf of: (i) DCM VI, L.P., a Cayman Islands exempted limited partnership (“DCM VI”),
(ii) A-Fund, L.P., a Cayman Islands exempted limited partnership (“A-Fund”), (iii) DCM Investment Management VI, L.P.,
a Cayman Islands exempted limited partnership (“DGP VI”), (iv) DCM International VI, Ltd., a Cayman Islands exempted company
(“UGP VI”), (v) A-Fund Investment Management, L.P., a Cayman Islands exempted limited partnership (“A-Fund DGP”),
(vi) A-Fund International, Ltd., a Cayman Islands exempted company (“A-Fund UGP”), and (vii) F. Hurst Lin (“Lin”),
a citizen of the United States, and (viii) Matthew C. Bonner (“Bonner”), a citizen of the United States, (the foregoing entities
and individuals are collectively referred to as the “Reporting Persons”).
DCM
VI and A-Fund are venture capital funds. DGP VI is the general partner of DCM VI and UGP VI is the general partner of DGP VI. A-Fund
DGP is the general partner of A-Fund and A-Fund UGP is the general partner of A-Fund DGP. Lin and Bonner are the directors of each of
UGP VI and A-Fund UGP (collectively, the “Directors”). The principal business office of the Reporting Persons is 2420 Sand
Hill Road, Suite 200, Menlo Park, California 94025.
(d)
None of the Reporting Persons, individually or collectively, has, during the last five years, been convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors).
(e)
None of the Reporting Persons has, during the last five years, been a party to a civil proceeding of a judicial or administrative body
of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect
to such laws.
| ITEM 3. | SOURCE
AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. |
The
information set forth in Item 4 hereof is hereby incorporated by reference into this Item 3, as applicable.
On
October 5, 2020, pursuant to the Agreement and Plan of Merger and Reorganization, dated as of October 5, 2020 (the “Merger Agreement”),
by and among Malo Holdings Corporation, a Delaware corporation (the “Parent”), August Acquisition Corp., a Delaware
corporation (the “Acquisition Subsidiary”), and Augmedix, Inc., a privately held
Delaware corporation ("Augmedix"), the Acquisition Subsidiary merged with and into Augmedix and the separate corporate
existence of the Acquisition Subsidiary ceased, and the Company continued as the surviving corporation in the Merger (the “Merger”).
As a result of the Merger, all of the outstanding shares of stock of Augmedix held by accredited
investors were converted into shares of the Company's common stock. All of the outstanding warrants, options and stock appreciation rights
of Augmedix were assumed by the Company. The foregoing description of the Merger and the Merger Agreement is intended as a summary
only and is qualified in their entirety by reference to the Merger Agreement, which is filed with the Securities and Exchange Commission
as as Exhibit 2.1 to the Company’s Form 8-K filed on October 9, 2020 and is incorporated herein by reference.
CUSIP NO. 05105P107 | 13D | Page 11 of 26 Pages |
At
the time the certificate of merger reflecting the Merger was filed with the Secretary of State of Delaware (the “Effective Time”),
each of Augmedix’s shares of capital stock issued and outstanding immediately prior to the closing of the Merger was converted
into the right to receive (a) 0.420864013 shares of the Company’s common stock (the “Common Share Conversion Ratio”)
(in the case of shares held by accredited investors) or (b) $3.00 multiplied by the Common Share Conversion Ratio (in the case of shares
held by unaccredited investors and those with an entitlement to shares of Augmedix’s capital stock), with the maximum number of
shares of Company’s common stock issuable to the former holders of Augmedix’s capital stock equal to 15,458,133 after adjustments
due to rounding for fractional shares.
In
March 2018, DCM VI purchased in a private placement a convertible promissory note in the amount of $658,613 at an interest rate 6% per
annum.
In
May 2018, DCM VI entered into a Series B Preferred Stock Purchase Agreement with Augmedix to acquire an aggregate of 1,540,245 shares
of Series B convertible preferred stock for an aggregate purchase price of $1,841,386.00.
In
October 2018, DCM VI entered into a Series A Preferred Stock Purchase Agreement with Augmedix to acquire an aggregate of 16,666,665 shares
of Series A convertible preferred stock (before giving effect to a 10-for-1 reverse stock split in March 2019) for a purchase price
of $0.20 per share, an aggregate purchase price of $3,333,333.00.
In
August 2019, DCM VI purchased in a private placement a convertible promissory note in the amount of $953,078 at an interest of 6% per
annum.
In
September 2019, DCM VI entered into a 2019 Series B Preferred Stock and Warrant Purchase Agreement dated September 3, 2019 with Augmedix
to acquire an aggregate of 2,031,992 shares of 2019 Series B convertible preferred stock for an aggregate purchase price of $2,354,543.
On
October 5, 2020, DCM VI entered into a Subscription Agreement pursuant to which DCM VI acquired from the Company in an initial closing
of a private placement offering an aggregate of 666,667 shares of common stock for a purchase price of $3.00 per share, or $2,000,001.00
in the aggregate.
In
connection with the Merger, DCM VI received 3,064,751 shares of common stock of the Company in exchange for its Series A Preferred Stock
and Series B Preferred Stock of Augmedix.
In
connection with the Merger, A-Fund received 20,007 shares of common stock of the Company in exchange for its Series A Preferred Stock
and Series B Preferred Stock of Augmedix.
In
connection with the Merger, DCM VI received 269,490 shares of common stock of the Company in exchange for warrants assumed in the Merger.
On
October 28, 2021, DCM VI entered into a Subscription Agreement to which DCM VI acquired from the Company in an initial closing of a private
placement offering an aggregate of 437,500 shares of common stock for a purchase price of $4.00 per share, or $1,750,000.00 in the aggregate.
The
source of the funds for all purchases and acquisitions by the Reporting Persons was from working capital.
No
part of the purchase price was borrowed by any Reporting Person for the purpose of acquiring any securities discussed in this Item 3.
| ITEM
4. | PURPOSE
OF TRANSACTION. |
The
shares of the Company’s common stock acquired by the Reporting Persons in the Merger (described in Item 3 above) were acquired
solely for investment purposes. The information set forth in Item 3 hereof is hereby incorporated by reference into this Item 4, as applicable.
The
Reporting Persons consummated the transactions described herein in order to acquire an interest in the Company for investment purposes
in the ordinary course of business. The Reporting Persons expect to evaluate the Company’s financial condition and prospects and
their respective interests in, and intentions with respect to, the Company and their respective investments in the securities of the
Company, on an on-going basis, which review may be based on various factors, including the Company’s business and financial condition,
results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Company’s
securities in particular, as well as other developments and other investment opportunities. Accordingly, each Reporting Person reserves
the right to change its intentions, as it deems appropriate. In particular, each Reporting Person may at any time and from time to time,
in the open market, in privately negotiated transactions or otherwise, increase or decrease its holdings in the Company that the Reporting
Persons now own or may hereafter acquire, including sales pursuant to the exercise of the registration rights provided by the Registration
Rights Agreement dated as of October 5, 2020, by and among the Company, DCM VI and certain other parties thereto.
CUSIP NO. 05105P107 | 13D | Page 12 of 26 Pages |
Except
as set forth in this Item 4, the Reporting Persons have no present plans or proposals that relate to or would result in any of the actions
described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. The Reporting Persons do, however, reserve the right in the future
to adopt such plans or proposals subject to compliance with applicable regulatory requirements.
| ITEM 5. | INTEREST
IN SECURITIES OF THE ISSUER. |
(a,b) Regarding
aggregate beneficial ownership, see Row 9 of the cover page of each Reporting Person. Regarding percentage beneficial ownership, see
Row 11 of the cover page of each Reporting Person. Regarding sole power to vote shares, see Row 5 of the cover page of each Reporting
Person. Regarding shared power to vote shares, see Row 6 of the cover page of each Reporting Person. Regarding sole power to dispose
of shares, see Row 7 of the cover page of each Reporting Person. Regarding shared power to dispose of shares, see Row 8 of the cover
page of each Reporting Person. Persons may be deemed to constitute a “group” for purposes of Section 13(d)(3) of the
Act. The filing of this Statement shall not be construed as an admission that the Reporting Persons are a group, or have agreed to act
as a group. Each Reporting Person expressly disclaims beneficial ownership in the securities reported herein except to the extent such
Reporting Person actually exercises voting or dispositive power with respect to such securities. The percentage listed in Row 13 for
each Reporting Person was calculated based upon 37,432,204 outstanding shares
of common stock outstanding as disclosed by the Company in its Form 10-Q filed on November 2, 2022.
(c)
Except as set forth in Item 3 above, the Reporting Persons have not effected any transaction
in the common stock of the Company during the past 60 days.
(d) Under
certain circumstances set forth in the limited partnership agreement of each of DCM VI, A-Fund, DGP VI, A-Fund DGP and the amended and
restated articles of memorandum and association of UGP VI and A-Fund UGP, the partners and shareholders of each of such entities, as
applicable, may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the Company owned
by each such entity of which they are a partner or shareholder.
(e) Not
applicable.
| ITEM 6. | CONTRACTS,
ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER. |
The
information set forth and/or incorporated by reference in Items 2, 3, 4 and 5 is hereby incorporated by reference into this Item 6.
In
connection with the acquisition of common stock of the Company, DCM VI and certain other investors entered into a Subscription Agreement
and a Registration Rights Agreement dated as of October 5, 2020, entitling such parties to the registration of their shares, including
demand registration rights, Form S-4 or Form S-8 registration rights, deferral of registration, and piggyback registration
filed with the Securities and Exchange Commission as Exhibit 10.9 and Exhibit 10.8 to the Company’s Form 8-K filed on October 9,
2020 and are incorporated herein by reference, respectively.
On
October 25, 2021, certain of the Reporting Persons and certain other investors entered into lock-up agreements (the “Lock-Up
Agreements”) pursuant to which certain of the Reporting Persons agreed, subject to certain exceptions, not
to sell, transfer or otherwise dispose of or hedge any shares of Common Stock (or securities
convertible into or exchangeable for shares of Common Stock) held by each of them during the period commencing upon the date
of the lock-up agreements until the date that is 90 days after the date of the Prospectus, except with the prior written consent
of the representatives.
CUSIP NO. 05105P107 | 13D | Page 13 of 26 Pages |
| ITEM 7. | MATERIAL
TO BE FILED AS EXHIBITS. |
CUSIP NO. 05105P107 | 13D | Page 14 of 26 Pages |
SIGNATURES
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete
and correct.
Date:
January 23, 2023
|
DCM
VI, L.P. |
|
|
|
By:
DCM Investment Management VI, L.P. |
|
Its
General Partner |
|
|
|
By:
DCM International VI, Ltd. |
|
Its
General Partner |
|
|
|
By:
|
/s/
Matthew C. Bonner |
|
|
Matthew
C. Bonner, Attorney-In-Fact* |
|
|
|
DCM
INVESTMENT MANAGEMENT VI, L.P. |
|
|
|
By:
DCM International VI, Ltd. |
|
Its
General Partner |
|
|
|
By: |
/s/
Matthew C. Bonner |
|
|
Matthew
C. Bonner, Attorney-In-Fact* |
|
|
|
DCM
International VI, Ltd. |
|
|
|
By: |
/s/
Matthew C. Bonner |
|
|
Matthew
C. Bonner, Attorney-In-Fact* |
|
|
|
A-FUND,
L.P. |
|
|
|
By:
A-FUND INVESTMENT MANAGEMENT, L.P. |
|
Its
General Partner |
|
|
|
By:
A-FUND INTERNATIONAL, LTD. |
|
Its
General Partner |
|
|
|
By:
|
/s/
Matthew C. Bonner |
|
|
Matthew
C. Bonner, Attorney-In-Fact* |
|
|
|
A-FUND
INVESTMENT MANAGEMENT, L.P. |
|
|
|
By:
A-FUND INTERNATIONAL, LTD. |
|
Its
General Partner |
|
|
|
By:
|
/s/
Matthew C. Bonner |
|
|
Matthew
C. Bonner, Attorney-In-Fact* |
CUSIP NO. 05105P107 | 13D | Page 15 of 26 Pages |
|
A-FUND
INTERNATIONAL, LTD. |
|
|
|
By:
|
/s/
Matthew C. Bonner |
|
|
Matthew
C. Bonner, Attorney-In-Fact* |
|
|
|
F.
HURST LIN |
|
|
|
/s/
F. Hurst Lin |
|
Matthew
C. Bonner, Attorney-In-Fact* |
|
|
|
|
|
MATTHEW
C. BONNER |
|
|
|
/s/
Matthew C. Bonner |
|
Matthew
C. Bonner |
*
Signed pursuant to a Power of Attorney already on file with the appropriate agencies.
CUSIP NO. 05105P107 | 13D | Page 16 of 26 Pages |
exhibit
A
Agreement
of Joint Filing
The
undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Augmedix, Inc. shall be
filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
Date:
January 23, 2023
|
DCM
VI, L.P. |
|
|
|
By:
DCM Investment Management VI, L.P. |
|
Its
General Partner |
|
|
|
By:
DCM International VI, Ltd. |
|
Its
General Partner |
|
|
|
By:
|
/s/
Matthew C. Bonner |
|
|
Matthew
C. Bonner, Attorney-In-Fact* |
|
|
|
DCM
INVESTMENT MANAGEMENT VI, L.P. |
|
|
|
By:
DCM International VI, Ltd. |
|
Its
General Partner |
|
|
|
By: |
/s/
Matthew C. Bonner |
|
|
Matthew
C. Bonner, Attorney-In-Fact* |
|
|
|
DCM
International VI, Ltd. |
|
|
|
By: |
/s/
Matthew C. Bonner |
|
|
Matthew
C. Bonner, Attorney-In-Fact* |
|
|
|
A-FUND,
L.P. |
|
|
|
By:
A-FUND INVESTMENT MANAGEMENT, L.P. |
|
Its
General Partner |
|
|
|
By:
A-FUND INTERNATIONAL, LTD. |
|
Its
General Partner |
|
|
|
By:
|
/s/
Matthew C. Bonner |
|
|
Matthew
C. Bonner, Attorney-In-Fact* |
CUSIP NO. 05105P107 | 13D | Page 17 of 26 Pages |
|
A-FUND
INVESTMENT MANAGEMENT, L.P. |
|
|
|
By:
A-FUND INTERNATIONAL, LTD. |
|
Its
General Partner |
|
|
|
By:
|
/s/
Matthew C. Bonner |
|
|
Matthew
C. Bonner, Attorney-In-Fact* |
|
|
|
|
|
A-FUND
INTERNATIONAL, LTD. |
|
|
|
By: |
/s/
Matthew C. Bonner |
|
|
Matthew
C. Bonner, Attorney-In-Fact* |
|
|
|
F.
HURST LIN |
|
|
|
/s/
F. Hurst Lin |
|
Matthew
C. Bonner, Attorney-In-Fact* |
|
|
|
|
|
MATTHEW
C. BONNER |
|
|
|
/s/
Matthew C. Bonner |
|
Matthew
C. Bonner |
*
Signed pursuant to a Power of Attorney already on file with the appropriate agencies.
CUSIP NO. 05105P107 | 13D | Page 18 of 26 Pages |
exhibit
A
dcm
Power
of Attorney
KNOW
ALL MEN BY THESE PRESENTS, that each of the undersigned hereby constitutes and appoints Matthew
C. Bonner his or its true and lawful attorney-in-fact (the “Attorney-in-Fact”) to:
(1) execute
for and on behalf of each undersigned (a “Reporting Person”) any and all reports, notices, communications and
other documents (including, but not limited to, reports on Schedule 13D, Schedule 13G, Form 13H, Form 13-F, Form 3, Form 4 and Form 5)
that such Reporting Person may be required to file with the United States Securities and Exchange Commission pursuant to the Securities
Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended (collectively, the “Reports”)
with respect to each Reporting Person’s (a) status as an officer or director of, or (b) ownership of, or transactions in, securities
of, any entity whose securities are beneficially owned (directly or indirectly) by such Reporting Person (each, a “Company”);
(2) do
and perform any and all acts for and on behalf of each Reporting Person which may be necessary or desirable to complete and execute any
such Reports and timely file such forms and schedules with the United States Securities and Exchange Commission and any stock exchange
or similar authority or the Form ADV; and
(3) take
any other action of any type whatsoever in connection with the foregoing which, in the opinion of either such attorney-in-fact, may be
of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by either
such attorney-in-fact on behalf of the undersigned, pursuant to this Power of Attorney, shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in his discretion.
The
undersigned hereby grants to the Attorney-in-Fact full power and authority to do and perform all and every act and thing whatsoever requisite,
necessary, and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes
as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or his substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney
and the rights and powers herein granted. The undersigned acknowledges that no such attorney-in-fact, in serving in such capacity at
the request of the undersigned, is hereby assuming, nor is the Company hereby assuming, any of the undersigned’s responsibilities
to comply with Section 16 or Section 13 of the Securities Exchange Act of 1934.
This
Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 or Schedules
13G/D with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked
by the undersigned in a signed writing delivered to the Attorney-in-Fact. Each Reporting Person acknowledges that the Attorney-in-Fact,
in serving in such capacity at the request of the undersigned, is not hereby assuming any of the undersigned’s responsibilities
to comply with state or federal securities laws.
[Signatures
on the Following Page.]
CUSIP NO. 05105P107 | 13D | Page 19 of 26 Pages |
IN
WITNESS WHEREOF, each of the undersigned has caused this Power of Attorney to be executed as of this 31st day of December, 2022.
/s/
F. Hurst Lin |
/s/
Matthew C. Bonner |
F. Hurst
Lin |
Matthew
C. Bonner |
|
|
DCM MANAGEMENT,
L.P. |
DCM
Management International, Ltd. |
|
|
By: DCM
Management International, Ltd., |
|
Its General
Partner |
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
By: /s/
Matthew C. Bonner |
Title:
Director |
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
|
DCM INTERNATIONAL
IV, LTD. |
DCM IV,
L.P. |
|
|
|
By: DCM
INVESTMENT MANAGEMENT IV, L.P. |
By: /s/
Matthew C. Bonner |
Its General
Partner |
Name:
Matthew C. Bonner |
|
Title:
Director |
By: DCM
INTERNATIONAL IV, LTD. |
|
Its General
Partner |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
DCM INVESTMENT
MANAGEMENT IV, L.P. |
DCM AFFILIATES
FUND IV, L.P. |
|
|
By: DCM
INTERNATIONAL IV, LTD. |
By: DCM
INVESTMENT MANAGEMENT IV, L.P. |
Its General
Partner |
Its General
Partner |
|
|
|
By: DCM
INTERNATIONAL IV, LTD. |
By: /s/
Matthew C. Bonner |
Its General
Partner |
Name:
Matthew C. Bonner |
|
Title:
Director |
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
DCM INTERNATIONAL
V, LTD. |
DCM V,
L.P. |
|
|
By: /s/
Matthew C. Bonner |
By: DCM
INVESTMENT MANAGEMENT V, L.P. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: DCM
INTERNATIONAL V, LTD. |
|
Its General
Partner |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
CUSIP NO. 05105P107 | 13D | Page 20 of 26 Pages |
DCM
INVESTMENT MANAGEMENT V, L.P. |
DCM
AFFILIATES FUND V, L.P. |
|
|
By: DCM
INTERNATIONAL V, LTD. |
By: DCM
INVESTMENT MANAGEMENT V, L.P. |
Its General
Partner |
Its General
Partner |
|
|
By: /s/
Matthew C. Bonner |
By: DCM
INTERNATIONAL V, LTD. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
DCM INTERNATIONAL
VI, LTD. |
DCM VI,
L.P. |
|
|
By: /s/
Matthew C. Bonner |
By: DCM
INVESTMENT MANAGEMENT VI, L.P. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: DCM
INTERNATIONAL VI, LTD. |
|
Its General
Partner |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
DCM INVESTMENT
MANAGEMENT VI, L.P. |
|
|
|
By: DCM
INTERNATIONAL VI, LTD. |
|
Its General
Partner |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
|
DCM INTERNATIONAL
VII, LTD. |
DCM VII,
L.P. |
|
|
By: /s/
Matthew C. Bonner |
By: DCM
INVESTMENT MANAGEMENT VII, L.P. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: DCM
INTERNATIONAL VII, LTD. |
|
Its General
Partner |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
CUSIP NO. 05105P107 | 13D | Page 21 of 26 Pages |
DCM
INVESTMENT MANAGEMENT VII, L.P. |
DCM
AFFILIATES FUND VIII, L.P. |
|
|
By: DCM
INTERNATIONAL VII, LTD. |
By: DCM
INVESTMENT MANAGEMENT VIII, L.P. |
Its General
Partner |
Its General
Partner |
|
|
By: /s/
Matthew C. Bonner |
By: DCM
INTERNATIONAL VIII, LTD. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
DCM INTERNATIONAL
VIII, LTD. |
DCM VIII,
L.P. |
|
|
By: /s/
Matthew C. Bonner |
By: DCM
INVESTMENT MANAGEMENT VIII, L.P. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: DCM
INTERNATIONAL VIII, LTD. |
|
Its General
Partner |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
DCM INVESTMENT
MANAGEMENT VIII, L.P. |
DCM
Ventures China Fund (DCM VIII), L.P. |
|
|
By: DCM
INTERNATIONAL VIII, LTD. |
By: DCM
INVESTMENT MANAGEMENT VIII, L.P. |
Its General
Partner |
Its General
Partner |
|
|
By: /s/
Matthew C. Bonner |
By: DCM
INTERNATIONAL VIII, LTD. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
DCM INTERNATIONAL
IX, LTD. |
DCM IX,
L.P. |
|
|
|
By: DCM
INVESTMENT MANAGEMENT IX, L.P. |
By: /s/
Matthew C. Bonner |
Its General
Partner |
Name:
Matthew C. Bonner |
|
Title:
Director |
By: DCM
INTERNATIONAL IX, LTD. |
|
Its General
Partner |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
CUSIP NO. 05105P107 | 13D | Page 22 of 26 Pages |
DCM
INVESTMENT MANAGEMENT IX, L.P. |
DCM
AFFILIATES FUND IX, L.P. |
|
|
By: DCM
INTERNATIONAL IX, LTD. |
By: DCM
INVESTMENT MANAGEMENT IX, L.P. |
Its General
Partner |
Its General
Partner |
|
|
By: /s/
Matthew C. Bonner |
By: DCM
INTERNATIONAL IX, LTD. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
DCM INTERNATIONAL
X, LTD. |
DCM X,
L.P. |
|
|
By: /s/
Matthew C. Bonner |
By: DCM
INVESTMENT MANAGEMENT X, L.P. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: DCM
INTERNATIONAL X, LTD. |
|
Its General
Partner |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
DCM INVESTMENT
MANAGEMENT X, L.P. |
DCM AFFILIATES
FUND X, L.P. |
|
|
By: DCM
INTERNATIONAL X, LTD. |
By: DCM
INVESTMENT MANAGEMENT X, L.P. |
Its General
Partner |
Its General
Partner |
|
|
By: /s/
Matthew C. Bonner |
By: DCM
INTERNATIONAL X, LTD. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
A-FUND
INTERNATIONAL, LTD. |
A-FUND,
L.P. |
|
|
|
By: A-FUND
INVESTMENT MANAGEMENT, L.P. |
By: /s/
Matthew C. Bonner |
Its General
Partner |
Name:
Matthew C. Bonner |
|
Title:
Director |
By: A-FUND
INTERNATIONAL, LTD. |
|
Its General
Partner |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
CUSIP NO. 05105P107 | 13D | Page 23 of 26 Pages |
A-FUND
INVESTMENT MANAGEMENT, L.P. |
|
|
|
By: A-FUND
INTERNATIONAL, LTD. |
|
Its General
Partner |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
|
A-FUND
INTERNATIONAL II, LTD. |
A-FUND
II, L.P. |
|
|
|
By: A-FUND
INVESTMENT MANAGEMENT II, L.P. |
By: /s/
Matthew C. Bonner |
Its General
Partner |
Name:
Matthew C. Bonner |
|
Title:
Director |
By: A-FUND
INTERNATIONAL II, LTD. |
|
Its General
Partner |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
A-FUND
INVESTMENT MANAGEMENT II, L.P. |
A-FUND
II AFFILIATES FUND, L.P. |
|
|
By: A-FUND
INTERNATIONAL II, LTD. |
By: A-FUND
INVESTMENT MANAGEMENT II, L.P. |
Its General
Partner |
Its General
Partner |
|
|
By: /s/
Matthew C. Bonner |
By: A-FUND
INTERNATIONAL II, LTD. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
A-FUND
INVESTMENT MANAGEMENT III, L.P. |
A-FUND
III, L.P. |
|
|
By: A-FUND
INTERNATIONAL III, LTD. |
By: A-FUND
INVESTMENT MANAGEMENT III, L.P. |
Its General
Partner |
Its General
Partner |
|
|
By: /s/
Matthew C. Bonner |
By: A-FUND
INTERNATIONAL III, LTD. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
CUSIP NO. 05105P107 | 13D | Page 24 of 26 Pages |
A-FUND
INTERNATIONAL III, LTD. |
A-FUND
III AFFILIATES FUND, L.P. |
|
|
By: /s/
Matthew C. Bonner |
By: A-FUND
INVESTMENT MANAGEMENT III, L.P. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: A-FUND
INTERNATIONAL III, LTD. |
|
Its General
Partner |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
DCM HYBRID
RMB FUND INVESTMENT MANAGEMENT, L.P. |
DCM HYBRID
RMB FUND, L.P. |
|
|
By: DCM
HYBRID RMB FUND INTERNATIONAL, LTD. |
By: DCM
HYBRID RMB FUND INVESTMENT MANAGEMENT, L.P. |
Its General
Partner |
Its General
Partner |
|
|
By: /s/
Matthew C. Bonner |
By: DCM
HYBRID RMB FUND INTERNATIONAL, LTD. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Boner |
|
Title:
Director |
|
|
DCM HYBRID
RMB FUND INTERNATIONAL, LTD. |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
|
DCM
Turbo Fund Investment Management, L.P. |
DCM
Ventures China Turbo Fund, L.P. |
|
|
By: DCM
Turbo Fund International, Ltd. |
By: DCM
Turbo Fund Investment Management, L.P. |
Its General
Partner |
Its General
Partner |
|
|
By: /s/
Matthew C. Bonner |
By: DCM
Turbo Fund International, Ltd. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
CUSIP NO. 05105P107 | 13D | Page 25 of 26 Pages |
DCM
Turbo Fund International, Ltd. |
DCM
Ventures China Turbo AFFILIATES Fund, L.P. |
|
|
|
By: DCM
Turbo Fund Investment Management, L.P. |
By: /s/
Matthew C. Bonner |
Its General
Partner |
Name:
Matthew C. Bonner |
|
Title:
Director |
By: DCM
Turbo Fund International, Ltd. |
|
Its General
Partner |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
DCM
Opportunity Fund Investment Management III, L.P. |
DCM
Opportunity Fund III, L.P. |
|
|
By: DCM
Opportunity Fund International III, Ltd. |
By: DCM
Opportunity Fund Investment Management III, L.P. |
Its General
Partner |
Its General
Partner |
|
|
|
By: DCM
Opportunity Fund International III, Ltd. |
By: /s/
Matthew C. Bonner |
Its General
Partner |
Name:
Matthew C. Bonner |
|
Title:
Director |
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
DCM
Opportunity Fund International III, Ltd. |
DCM Opportunity
Fund International II, Ltd. |
|
|
By: /s/
Matthew C. Bonner |
By: /s/
Matthew C. Bonner |
Name:
Matthew C. Bonner |
Name:
Matthew C. Bonner |
Title:
Director |
Title:
Director |
|
|
DCM
Opportunity Fund Investment Management II, L.P. |
DCM
Opportunity Fund II, L.P. |
|
|
By: DCM
Opportunity Fund International II, Ltd. |
By: DCM
Opportunity Fund Investment Management II, L.P. |
Its General
Partner |
Its General
Partner |
|
|
|
By: DCM
Opportunity Fund International II, Ltd. |
By: /s/
Matthew C. Bonner |
Its General
Partner |
Name:
Matthew C. Bonner |
|
Title:
Director |
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
CUSIP NO. 05105P107 | 13D | Page 26 of 26 Pages |
DCM
Opportunity Fund Investment Management, L.P. |
DCM
Opportunity Fund, L.P. |
|
|
By: DCM
Opportunity Fund International, Ltd. |
By: DCM
Opportunity Fund Investment Management, L.P. |
Its General
Partner |
Its General
Partner |
|
|
By: /s/
Matthew C. Bonner |
By: DCM
Opportunity Fund International, Ltd. |
Name:
Matthew C. Bonner |
Its General
Partner |
Title:
Director |
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
DCM
Opportunity Fund International, Ltd. |
|
|
|
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Director |
|
|
|
DCM
III, L.P. |
DCM
III-A, L.P. |
|
|
By:
DCM Investment Management III, L.L.C. |
By:
DCM Investment Management III, L.L.C. |
Its General
Partner |
Its General
Partner |
|
|
By: /s/
Matthew C. Bonner |
By: /s/
Matthew C. Bonner |
Name:
Matthew C. Bonner |
Name:
Matthew C. Bonner |
Title:
Authorized Signatory |
Title:
Authorized Signatory |
|
|
DCM
Investment Management III, L.L.C. |
DCM AFFILIATES
FUND III, L.P. |
|
|
|
By:
DCM Investment Management III, L.L.C. |
By: /s/
Matthew C. Bonner |
Its General
Partner |
Name:
Matthew C. Bonner |
|
Title:
Authorized Signatory |
By: /s/
Matthew C. Bonner |
|
Name:
Matthew C. Bonner |
|
Title:
Authorized Signatory |